The ACRE highlights an important new publication exploring the genetic foundations of coronary artery disease. Recent research featured in the European Heart Journal uncovers the variant-to-function relationship at the LIPA locus—offering deeper insight into how genetic variation contributes to cardiovascular risk.

Led by Hanrui Zhang, PhD, of the Columbia University Irving Medical Center, this study advances our understanding of the biological pathways that influence coronary artery disease. By connecting genetic signals with functional outcomes, the work provides a clearer picture of disease mechanisms and may help inform future precision-medicine approaches.

Why This Research Matters

Coronary artery disease remains one of the leading causes of morbidity and mortality worldwide. Investigations like this are essential for:

• Identifying genetic drivers of disease risk
• Clarifying molecular pathways involved in atherosclerosis
• Supporting the development of targeted therapies and preventive strategies

Dr. Zhang’s research represents a meaningful step forward in cardiovascular

Despite decades of efforts, cardiovascular diseases (CVDs) and related heart failure continue
to be the leading cause of morbidity and mortality globally and have a progressively increasing prevalence. It is increasingly recognized that CVDs must be detected early in order for medical intervention to be effective.

Achieving the goal of early detection of CVD requires specific prognostic biomarkers for early CVD detection and sensing technologies capable of sensitively detecting the biomarkers in various biological samples. Therefore, discovering novel biomarkers and developing unique sensor technology platforms and devices for biomarker detections play a central role in early identification and medical intervention of CVDs and potential heart failure. Continue reading >

Reprogramming cardiomyocytes from other cell types could have therapeutic potential for cardiac diseases. Wang et al. studied the induction of cardiomyocytes from murine fibroblasts. They found that autophagy-related 5 (Atg5) regulated autophagy during early cell reprogramming, whereas the autophagic factor Beclin1 inhibited cardiomyocyte induction.

In cell and mouse models, the authors showed that loss of Beclin1 resulted in gene expression changes in reprogramming cells, activation of Wnt signaling, and reduction of scar size after myocardial infarction. This study helps identify the roles of autophagy-dependent and -independent signaling pathways in cardiac fate determination.

Continue reading >